血脂康对血脂正常的高血压患者颈动脉内膜中层厚度的影响

目的观察应用血脂康对血脂正常的高血压患者颈动脉内膜中层厚度（IMT）的影响。方法共纳入血脂正常的高血压患者65例，随机分为血脂康组33例，对照组32例。两组均给予氨氯地平、依那普利口服治疗，血脂康组在此基础上加用血脂康口服，疗程为12周，观察治疗前后血脂、血压、脉压、IMT的变化。结果1、血脂康组治疗后进一步降低血脂水平（P〈0．05）；2、与对照组治疗后比较，血脂康组治疗后进一步降低24小时平均收缩压、脉压水平（P〈0．05）；3、与对照组治疗后比较，血脂康组治疗后可降低IMT（P〈0．05）。结论血脂康能明显改善血脂正常的高血压患者的IMT。

Effect of Xuezhikang on the Tntima-media Thickness of Carotid Artery in Patients With Hypertension and Normal Blood Lipids

Objective To observe the effect of Xuezhikang on the intima-media thickness （IMT） of carotid artery in patients with hypertension and normal blood lipids. Methods 65 cases of hypertensive patients with normal blood lipids were randomly divided into a treatment group （ n = 33） and a control group （ n = 32）. Both groups were given amlodipine besylate tablet and enalapril maleate tablet. The treatment group was extra treated with Xuezhikang. Experiments were continued for 12 weeks. The changes of blood lipids, blood pressure, pulse pressure and IMT of carotid artery were observed at the beginning and at the end of experiment. Results After the treatment,blood lipids, systolic readings and blood pressure by an average, and IMT of carotid artery in the treatment group decreased significantly compared with the control group （P 〈 0. 05 ）. Conclusions Xuezhikang significantly improves IMT of carotid artery in hypertensive patients with normal blood lipids.